-+ 0.00%
-+ 0.00%
-+ 0.00%

ALNYLAM PHARMACEUTICALS, INC. : WELLS FARGO CUTS TARGET PRICE TO $256 FROM $316

Reuters·08/14/2026 10:27:22

Please log in to view news